Dahl Andrew M. 4
4 · Edwards Lifesciences Corp · Filed May 9, 2025
Insider Transaction Report
Form 4
Dahl Andrew M.
SVP, Corporate Controller
Transactions
- Award
Common Stock
2025-05-08+3,335→ 8,106.527 total - Award
Employee Stock Option (Right to Acquire)
2025-05-08+5,670→ 5,670 totalExercise: $74.63From: 2026-05-08Exp: 2032-05-07→ Common Stock (5,670 underlying)
Footnotes (2)
- [F1]These restricted stock units were granted on May 8, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments.
- [F2]These options were granted on May 8, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments.